BRIEF published on 08/06/2024 at 22:10, 1 year 7 months ago Nyxoah Reports Financial Results for Q2 and H1 2024 Revenue Growth Capital Raise Operational Highlights FDA Submission Q2 2024 Results
PRESS RELEASE published on 08/06/2024 at 22:05, 1 year 7 months ago Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results Nyxoah SA reports financial and operating results for the second quarter and first half of 2024, including FDA submission completion and U.S. approval progress Financial Results Operating Results FDA Submission Nyxoah SA U.S. Approval
BRIEF published on 07/15/2024 at 08:20, 1 year 8 months ago Nyxoah Appoints Scott Holstine as Chief Commercial Officer FDA Approval Medical Device Industry Nyxoah Obstructive Sleep Apnea Scott Holstine
PRESS RELEASE published on 07/15/2024 at 08:15, 1 year 8 months ago Nyxoah Appoints Scott Holstine as Chief Commercial Officer Nyxoah appoints Scott Holstine as Chief Commercial Officer, bringing 26 years of medical device industry experience. His role is crucial for Nyxoah's U.S. launch success in treating Obstructive Sleep Apnea Chief Commercial Officer Medical Technology Nyxoah Obstructive Sleep Apnea Scott Holstine
BRIEF published on 07/03/2024 at 12:35, 1 year 9 months ago Nyxoah Signs €37.5 Million Loan Agreement with European Investment Bank Loan Agreement Medical Technology European Investment Bank Nyxoah Obstructive Sleep Apnea
PRESS RELEASE published on 07/03/2024 at 12:30, 1 year 9 months ago Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank Nyxoah signs a €37.5 million loan facility agreement with the European Investment Bank to boost research, development, and manufacturing capacity for sleep apnea solutions Research And Development European Investment Bank Sleep Apnea Nyxoah €37.5 Million Loan
Published on 04/02/2026 at 22:00, 1 day 22 hours ago Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Published on 04/02/2026 at 18:32, 2 days 1 hour ago Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Published on 04/02/2026 at 15:00, 2 days 5 hours ago Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 2 days 5 hours ago Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 2 days 5 hours ago Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution
Published on 04/04/2026 at 10:07, 9 hours 56 minutes ago Heidelberg Pharma to Present Data from its ADC Technology Platform at AACR Annual Meeting 2026
Published on 04/04/2026 at 02:05, 17 hours 57 minutes ago Blokees made its debut at 2026 Thailand Toy Expo, exhibiting multiple products
Published on 04/03/2026 at 18:00, 1 day 2 hours ago IEVA GROUP: IMPLEMENTATION OF A LIQUIDITY AGREEMENT WITH CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 17:45, 1 day 2 hours ago Atbash Launches on Chromia to Enable Verifiable, User-Controlled AI Systems
Published on 04/03/2026 at 17:05, 1 day 2 hours ago At WMF a new edition of AI Global Summit, an international reference point on Artificial Intelligence
Published on 04/03/2026 at 18:46, 1 day 1 hour ago Disclosure of Share Capital and Voting Rights as of March 31, 2026
Published on 04/03/2026 at 17:45, 1 day 2 hours ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 04/03/2026 at 17:45, 1 day 2 hours ago Information concerning the total number of voting rights and shares 2026 03 31
Published on 04/03/2026 at 17:45, 1 day 2 hours ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
